Obstructive sleep apnea risk and its association with diabetic foot ulcer in patients with type 2 diabetes

• by Raquel Ruano, María Teresa Charles, Josep León-Mengíbar, Ferran Barbé, Angel Michael Ortiz-Zúñiga, Marta Hernández, Cristina Hernández, Rafael Simó, Albert Lecube

• May 29, 2026

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

• by Kerri Miller

• March 11, 2026

• 5 min

AI Screening for Diabetic Retinopathy

• by Abraham Olvera-Barrios, MD, PhD, Cathy Egan, FRANZCO

• May 1, 2026

• 18 min

Keeping an Eye on Diabetes

Progress, pitfalls and the future of the UK’s Diabetic Eye Screening Program

• by Devansh Tandon

• April 28, 2026

• 7 min